Industry
Pharmaceuticals
Topic
Mergers and Acquisitions
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Mergers and Acquisitions in Pharmaceuticals
... available for free. (Fortune) INDICATIONS Juno shares fly to the moon on Celgene speculation. Juno Therapeutics' stock shot up a whopping 53% in Wednesday trading ...
... Sciences Inc. (CSE: NSHS) (formerly Corazon Gold Corp.) completes acquisition of NanoSphere Health Sciences, LLC, $6.0m financing, name change, and listing on the Canadian Securities ...
... Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment ...
... in countries around the world. Namaste, through its wholly owned subsidiary, Cannmart Inc. ("Cannmart") is developing an online marketplace for medical cannabis that will offer ...
... Adult Growth Hormone Deficiency, a Rare Endocrine Disorder ~ ~ MACRILEN is Strongbridge's Second Commercial Product; Expands the Company's Rare Endocrine Disease Portfolio and Complements ...
... Tetra Bio-Pharma Announces the Signature of a Letter of Intent to Monetize GrowPros and its Late Stage ACMPR Application OTTAWA, ONTARIO--(Marketwired - Dec. 21, 2017) ...
... to get any credit from Wall Street. That's intriguing." Others Shares of Incyte got hit hard after the conference, but the company didn't report any ...
... Celgene is looking to buy yet another biotech company. The Summit, New Jersey-based ...
... AMERICAN DAILY STOCK REPORT Generex Biotechnology (OTCQX:GNBT), OTC's 2nd largest Health care company by market cap, has ...
... CANADIAN DAILY STOCK REPORT Medicure Inc. (TSXV:MPH), Canada's 16th largest Biotechnology company by market cap, has fallen 7.0c ...
... CANADIAN DAILY STOCK REPORT Vanc Pharmaceuticals Inc. (TSXV:VANC), Canada's 14th largest Drug manufacturers company by market cap, extended ...
... CANADIAN DAILY STOCK REPORT CRH Medical Corporation (TSX:CRH), Canada's 2nd largest Medical instruments & equipment company by market ...
... following the closing of the placement. About Aurora Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health ...
... ANNOUNCEMENT [Text] MISSISSAUGA, ON, Jan. 15, 2018 /CNW/ - Nuvo Pharmaceuticals Inc.(TradeMark) (Nuvo or the Company) (TSX: NRI; OTCQX: NRIFF), a commercial healthcare company with ...
... Golden Leaf Holdings Ltd.(CSE: GLH) (OTC: GLDFF) andThe Supreme Cannabis Company, Inc.(formerly Supreme Pharmaceuticals) (TSX-V: FIRE) (OTC: SPRWF). For more information on DOJA Cannabis Company, ...
... In consideration of the investment, Atlas and Namaste's wholly owned subsidiary, Cannmart Inc. ("Cannmart") have entered in to a Supply Agreement (the "Supply Agreement") whereby ...
... YOFOTO (China) Health Industry Co. Ltd to Invest in Becoming RepliCel's Strategic Partner for Greater China Terms Include an Up-front Investment of USD ...
... for real value through the combination of these two great companies CanniMed Therapeutics Inc. (TSX:CMED) ("CanniMed" or the "Company") is pleased to announce that Glass ...
... CANADIAN DAILY STOCK REPORT Cipher Pharmaceuticals Inc. (TSX:CPH), Canada's 17th largest Biotechnology company by market cap, hit a ...
... Vancouver, B.C. - Alliance Growers Corp. (CSE: ACG; FWB: 1LA; WKN: A2DFYX) ('Alliance Growers' or the 'Company') ...
... globally -- Opens access to ~US$255 million head lice market - Nuvo Pharmaceuticals Inc.(TM)(Nuvo or the Company) (TSX: NRI; OTCQX: NRIFF), a commercial healthcare company ...
... CanniMed Therapeutics Inc. (TSX:CMED) ("CanniMed" or the "Company") is pleased to announce that Glass ...
... TORONTO, Jan. 15, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (the "Company" or "MPX") (CSE:MPX) (OTC:MPXEF) today announced that further to ...
... rs Celgene Celgene chief Alles discusses deal to acquire Impact Biomedicines, strategy for 2018 ...
Want to see the full history on Mergers and Acquisitions in Pharmaceuticals? Upgrade to RelSci Pro now!
Start My Free Trial